Spectrophotometric Determination of Megagliptin and its Assay by Charge - Transfer Method using 2,3-Dichloro- 5,6 -Dicyano-1,4- Benzoquinone (DDQ)
Published in June 2017 Issue 3 (Vol. 7, Issue 3, 2017)

Keywords
Abstract
Authors (5)
I.Lakshmi Prasanna
Department’s of Physics1 and C...Department’s of Physics1 and ChemistryDepartment’s of Physics1 and ChemistryDepartment’s of Physics1 and Chemistry
View all publications →Nuzhath Fathima
Department’s of Physics1 and C...Department’s of Physics1 and ChemistryDepartment’s of Physics1 and ChemistryDepartment’s of Physics1 and Chemistry
View all publications →G.T.Naidu
Department’s of Physics1 and C...Department’s of Physics1 and ChemistryDepartment’s of Physics1 and ChemistryDepartment’s of Physics1 and Chemistry
View all publications →I.E.Chakravathy
Department’s of Physics1 and C...Department’s of Physics1 and ChemistryDepartment’s of Physics1 and ChemistryDepartment’s of Physics1 and Chemistry
View all publications →P. Raveendra Reddy
Department’s of Physics1 and C...Department’s of Physics1 and ChemistryDepartment’s of Physics1 and ChemistryDepartment’s of Physics1 and Chemistry
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
June 2017 Issue 3 (Vol. 7, Issue 3, 2017)Article Impact
How to Cite
Prasanna & Fathima & G.T.Naidu & I.E.Chakravathy & Raveendra, P. (2017). Spectrophotometric Determination of Megagliptin and its Assay by Charge - Transfer Method using 2,3-Dichloro- 5,6 -Dicyano-1,4- Benzoquinone (DDQ). American Journal of PharmTech Research, 7(3), 1-11. https://ajptr.com/articles/AJPTR73014
Article Actions
More from this Issue
Mineral Content of Psathyrella tuberculata (PAT.) Smith Commonly Consumed and Commercialized in the Local Markets of Abidjan (Côte d’ivoire)
Synthesis and Antimicrobial Activity of Some Novel 1, 3,4-Thiadiazole derivatives.
More by These Authors
Quantitative Structure-Activity Relationships (QSARs) Modeling of Anti-hypertensive Activity of Dichloroanilino Imidazoline Derivatives
2018 • Vol. 8, Issue 3
Read more →Post Approval Regulatory Requirements for A New Drug Application (NDA)
2013 • Vol. 3, Issue 1
Read more →RECENT DEVELOPMENT IN ORAL DELIVERY OF BISPHOSPHONATES - AN OVERVIEW.
2011 • Vol. 1, Issue 2
Read more →